Ugnay, Helen U.

HRN: 22-50-67  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2023
CEFUROXIME 750MG (VIAL)
02/03/2023
02/10/2023
IV
750mg
Q8h
Infected Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Duration  Wrong Duration

Overall appropriateness: No  Wrong Duration

Intervention



Type of Intervention done:

                    

           


Acceptance: